Wet Cupping Therapy in Ankylosing Spondylitis
Wet Cupping Therapy in Ankylosing Spondylitis: a Multicenter Quasi- Randomised Controlled Trial
This study evaluates the efficacy of wet cupping therapy in patients with ankylosing spondylitis.Wet cupping therapy will be applied to half of the patients plus routine pharmaceutical treatment while the other half will receive only pharmaceutics
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
In addition to the medical treatment, WCT will be applied once every 28 days , 3 times (Day 0, 28, 56) to the intervention group whereas the control group will not receive any intervention. The BASFI, BASDAI, CRP, FFD, VAS and Modified Schober (MSI) tests will be applied to both groups at 0 and 3 months.
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Karabük, Turkey (Türkiye)
- Karabuk University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age between 18-65 years
- Confirmed diagnosis of ankylosing spondylitis (AS) according to the modified New York criteria or the ASAS classification criteria for axial spondyloarthritis
- Active disease at enrolment, confirmed by a PM&R specialist
- Written informed consent and compliance with the study protocol
Exclusion Criteria:
- Having received WCT within the previous 3 months
- Contraindications to WCT (hemoglobin <9.5 g/dL, known bleeding or coagulation disorders, anticoagulant use or antiplatelet therapy other than aspirin <100 mg, INR >1.5, etc.)
- Pregnancy or breastfeeding
- Severe uncontrolled comorbidities (e.g., advanced cardiovascular disease, uncontrolled diabetes, active malignancy, severe psychiatric illness)
- Any change in AS medication during the study period
- Failure to complete either baseline or follow-up visits
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Wet cupping arm
This arm is the interventiom group and will receive three consecutive sessions of wet cupping therapy once a month. |
wet cupping therapy will be applied to participants in this arm for three sessions once a month |
|
No Intervention: Control arm
This arm is the control group and will not receive any intervention other than the routine medications |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
BASDAI
Time Frame: At 0 and 9th weeks
|
Change in the scores of The Bath Ankylosing Spondylitis Disease Activity Index |
At 0 and 9th weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Schober
Time Frame: At 0 and 9th weeks
|
Change in the scores of Modified Schober Test |
At 0 and 9th weeks
|
|
BASFI
Time Frame: At 0 and 9th weeks
|
Change in the scores of The Bath Ankylosing Spondylitis Functional Index |
At 0 and 9th weeks
|
|
VAS
Time Frame: At 0 and 9th weeks
|
Change in the scores of Visual Analogue Scale |
At 0 and 9th weeks
|
|
C Reactive Protein (CRP)
Time Frame: At 0 and 9th weeks
|
Changes in the values of CRP |
At 0 and 9th weeks
|
|
fingertip-to-floor distance (FFD),
Time Frame: 0 th and 9 th weeks
|
Changes in the values of fingertip-to-floor distance (FFD), |
0 th and 9 th weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- SBU177
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.